Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia

por Roloff, Gregory W., Lai, Catherine, Hourigan, Christopher S., Dillon, Laura W.
Publicado 2017

Colon cancer metastasis to the thyroid gland: report of a case with unique molecular profile

por Roloff, Gregory W., Yang, Zhiming, Wood, Lauren V., Neychev, Vladimir K.
Publicado 2016

Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy

por O’Connor, Timothy E., Shaw, Reid, Madero-Marroquin, Rafael, Roloff, Gregory W.
Publicado 2023

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia

por Ahmadmehrabi, Khashayar, Haque, Ali R., Aleem, Ahmed, Griffiths, Elizabeth A., Roloff, Gregory W.
Publicado 2021

Locus-specific gene repositioning in prostate cancer

por Leshner, Marc, Devine, Michelle, Roloff, Gregory W., True, Lawrence D., Misteli, Tom, Meaburn, Karen J.
Publicado 2016

Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia

por Dillon, Laura W., Hayati, Sheida, Roloff, Gregory W., Tunc, Ilker, Pirooznia, Mehdi, Mitrofanova, Antonina, Hourigan, Christopher S.
Publicado 2019

Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation

por Shaw, Reid, Haque, Ali R., Luu, Tyler, O’Connor, Timothy E., Hamidi, Adam, Fitzsimons, Jack, Varda, Bianca, Kwon, Danny, Whitcomb, Cody, Gregorowicz, Alex, Roloff, Gregory W., Bemiss, Bradford C., Kallwitz, Eric R., Hagen, Patrick A., Berg, Stephanie
Publicado 2023

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

por Saygin, Caner, Roloff, Gregory, Hahn, Christopher N., Chhetri, Rakchha, Gill, Saar, Elmariah, Hany, Talati, Chetasi, Nunley, Emma, Gao, Guimin, Kim, Aelin, Bishop, Michael, Kosuri, Satyajit, Das, Soma, Singhal, Deepak, Venugopal, Parvathy, Homan, Claire C., Brown, Anna, Scott, Hamish S., Hiwase, Devendra, Godley, Lucy A.
Publicado 2022

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

por Wong, Hong Yuen, Sung, Anthony D., Lindblad, Katherine E., Sheela, Sheenu, Roloff, Gregory W., Rizzieri, David, Goswami, Meghali, Mulé, Matthew P., Ramos, Nestor R., Tang, Jingrong, Thompson, Julie, DeStefano, Christin B., Romero, Kristi, Dillon, Laura W., Kim, Dong-Yun, Lai, Catherine, Hourigan, Christopher S.
Publicado 2019

Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors

por Roloff, Gregory W., Wen, Frank, Ramsland, Aubrianna, Artz, Andrew S., Kosuri, Satyajit, Stock, Wendy, Odenike, Olatoyosi, Larson, Richard A., Liu, Hongtao, Godley, Lucy A., Thirman, Michael J., Patel, Anand A., Daugherty, Christopher K., DuVall, Adam S., Nawas, Mariam T., Dworkin, Emily, Wool, Geoffrey D., Gurbuxani, Sandeep, Fitzpatrick, Carrie, Segal, Jeremy P., Wang, Peng, Drazer, Michael W.
Publicado 2023